Expertise in
23
conditions

Weiqing H. Wang

197 Ruijin 2nd Road, 
Shanghai, CN 
Expertise in
23
conditions
197 Ruijin 2nd Road, 
Shanghai, CN 

Overview

Weiqing Wang practices practicing medicine in Shanghai, China.

Wang is highly rated in 23 conditions, according to our data. Their clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Obesity, Sleeve Gastrectomy, and Gastrectomy.

They are actively involved in clinical research, co-authoring 676 peer reviewed articles and participating in 2 clinical trials.

Locations

197 Ruijin 2nd Road, Shanghai, 200025, China
Other Locations
197 Ruijin 2nd Road, Shanghai, China
No. 197 Ruijin 2nd Road, Shanghai, 200025, China
999 Xi Wang Road, Xiwang, 201801, China
227 South ChongQing Road, Shanghai, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Isocaloric Dietary Restriction vs. Bariatric Surgery for Obesity Treatment
Isocaloric Dietary Restriction vs. Bariatric Surgery for Obesity Treatment
Enrollment Status: Unknown
Publish Date: August 29, 2024
Intervention Type: Procedure, Dietary supplement
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial to Evaluate the Effect of Akkermansia Muciniphila WST01 Strain in Patients With Type 2 Diabetes
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial to Evaluate the Effect of Akkermansia Muciniphila WST01 Strain in Patients With Type 2 Diabetes
Enrollment Status: Unknown
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: WST01 Strain Product
Study Phase: Phase 2
View 1 Less Clinical Trial

676 Total Publications

Non-Invasive Glucose Monitoring Using mμSORS: A Population-Based Validation Study Across Diverse Patient Variability.
Non-Invasive Glucose Monitoring Using mμSORS: A Population-Based Validation Study Across Diverse Patient Variability.
Journal: Journal of diabetes science and technology
Published: August 18, 2026

Frequently Asked Questions about Weiqing H. Wang

Is Weiqing H. Wang a top-rated expert for Maturity Onset Diabetes of the Young?

MediFind is an objective health platform that identifies experts based on real-world data. Weiqing H. Wang is classified as an Distinguished expert for Maturity Onset Diabetes of the Young, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Weiqing H. Wang participate in research or clinical trials?

Yes. Weiqing H. Wang has published 676 articles and abstracts on conditions like Maturity Onset Diabetes of the Young. You can view a list of Weiqing H. Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wang's expertise for a condition
ConditionClose
    View All 19 Advanced Conditions
    View All 80 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile